MLchartDataset catalogue

ALK peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-009774

A peptide cancer vaccine directed against the receptor tyrosine kinase anaplastic lymphoma kinase (ALK), with potential immunostimulatory and antineoplastic activities. Upon administration, ALK peptide vaccine may elicit a cytotoxic T-lymphocyte (CTL) response against ALK-expressing tumor cells. ALK dysregulation and gene rearrangements are associated with a variety of tumor cell types.

Table 1. Record
IdentifierMLC-T-ONC-009774
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009774",
  "term": "ALK peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A peptide cancer vaccine directed against the receptor tyrosine kinase anaplastic lymphoma kinase (ALK), with potential immunostimulatory and antineoplastic activities. Upon administration, ALK peptide vaccine may elicit a cytotoxic T-lymphocyte (CTL) response against ALK-expressing tumor cells. ALK dysregulation and gene rearrangements are associated with a variety of tumor cell types.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/alk-peptide-vaccine/"
}

Record 643 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.